The epidemiology of imported and locally acquired dengue in Australia, 2012–2022

The epidemiology of imported and locally acquired dengue in Australia, 2012–2022

2024 | Asma Sohail, MBBS1,2, Katherine L. Anders, PhD1,3, Sarah L. McGuinnessID, PhD1,4,† and Karin Leder, PhD1,5,†
This study examines the epidemiological trends of imported and locally acquired dengue in Australia from 2012 to 2022, focusing on the impact of the *Wolbachia* mosquito population replacement method implemented in northern Queensland between 2011 and 2019. Between 2012 and 2022, 13,343 dengue cases were reported in Australia, with 94.2% being imported and 4.4% locally acquired. Locally acquired cases decreased from a peak in 2013 to zero in 2021-22, while imported cases primarily originated from Southeast Asia (74%), Southern and Central Asia (12%), and Oceania (11%). The annual incidence of imported dengue varied from 8.29/100,000 to 22.10/100,000 annual traveler movements, decreasing in 2020 and 2021 due to COVID-19-related border closures, and rebounding to 34.79/100,000 in 2022. DENV-2 and DENV-1 were the predominant serotypes. The study highlights the successful control of locally acquired dengue in Australia through the *Wolbachia* method and the importance of understanding travel destinations and patterns for effective dengue surveillance and control.This study examines the epidemiological trends of imported and locally acquired dengue in Australia from 2012 to 2022, focusing on the impact of the *Wolbachia* mosquito population replacement method implemented in northern Queensland between 2011 and 2019. Between 2012 and 2022, 13,343 dengue cases were reported in Australia, with 94.2% being imported and 4.4% locally acquired. Locally acquired cases decreased from a peak in 2013 to zero in 2021-22, while imported cases primarily originated from Southeast Asia (74%), Southern and Central Asia (12%), and Oceania (11%). The annual incidence of imported dengue varied from 8.29/100,000 to 22.10/100,000 annual traveler movements, decreasing in 2020 and 2021 due to COVID-19-related border closures, and rebounding to 34.79/100,000 in 2022. DENV-2 and DENV-1 were the predominant serotypes. The study highlights the successful control of locally acquired dengue in Australia through the *Wolbachia* method and the importance of understanding travel destinations and patterns for effective dengue surveillance and control.
Reach us at info@study.space